Our two-part webinar series will explore liability changes within the Life Sciences industry. Cooley’s international team will help you identify .. Read more the risks and challenges involved with these changes. Join us as we discuss the most significant liability exposures for life sciences companies in the next 2-3 years, in the context of global legal change. The COVID-19 pandemic, legislative regime changes (including Europe’s new medical devices suite of legislation) and significant political events (such as Brexit) have all profoundly impacted the global life sciences industry. Companies, now more than ever, should consider these complexities to ensure successful navigation and minimize litigation risk. We will discuss this topics from multi-stakeholder and multi-jurisdictional angles, touching upon product liability, commercial litigation, patent and regulatory legal aspects.
- Share your Experience